Application note: Validated quantitation and activity assay of antibody fragment molecule (Fab) for process development and quality control
Posted: 8 September 2020 | ForteBio | No comments yet
This application note by ForteBio explores antibody fragment molecule (Fab) for process development and quality control.
The analytical group at Boehringer Ingelheim, Fremont, US, needed a robust assay to measure the biological activity of an antibody fragment (Fab) molecule for in-process testing, as well as stability and lot release testing in their quality control (QC) department.
Octet platform solution
The group was able to develop a working Fab activity assay on the Octet® RED system in less than a week. Relative to the overnight incubation and four-hour assay time of their ELISA protocol, the Octet assay provided an analysis time of only one hour per 96-well microplate, including sample preparation time.
Related content from this organisation
- A label-free imaging technique for drug evaluation at single‑cell level
- Bispecific antibodies: the next generation of immuno-oncology drugs
- Oncology meets immunology – antibody-mediated regulation of the immune response
- Antibody therapeutics for COVID-19
- Defusing antibody neutralisers in AAV gene therapy
Related topics
Analytical techniques, Antibodies, Assays
Related organisations
ForteBio
